Company Search:
Advanced Search
Sponsored Links
Ascendis Pharma A/S - ADR Company Snapshot
Ascendis Pharma A/S - ADR operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ascendis Pharma A/S - ADR with three other companies in this sector in the United States: Crispr Therapeutics AG (2016 sales of $5.16 million ), Clinuvel Pharmaceuticals Limited ($5.11 million of which 100% was Biotechnology), and Regenxbio Inc ($4.59 million of which 100% was Biotechnology).

Sales Analysis.
  Stock Performance Chart for Ascendis Pharma A/S - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 46.58
(Figures in U.S. Dollars)
1 Week 16.7%   13 Weeks 26.5%  
4 Weeks 28.1%   52 Weeks 123.3%  
Ascendis Pharma A/S - ADR Key Data:
  Ticker: ASND Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 5,083,780
(Year Ending Jan 2017).
Employees: 101
  Currency: U.S. Dollars Market Cap: 1,693,930,656
  Fiscal Yr Ends: December Shares Outstanding: 36,366,051
  Share Type: Common Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.